GYNECARE PROSIMA* Pelvic Floor Repair System
Deviceprocedure for pelvic organ prolapse
Other names: mesh pelvic floor repari
NCT Number: NCT00521066
The purpose of this study is to is to evaluate the success of the GYNECARE PROSIMA* system in women with symptoms for pelvic organ prolapse (POP) requiring surgical correction of POP.
(*TRADEMARK)
Looking for future studies?
Notify Me18 year and older
Female
Observational
Royal Women's Hospital, Melbourne, Australia
The GYNECARE PROSIMA* system provides a simplified mesh repair, avoiding the need for dissection outside the pelvic cavity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
procedure for pelvic organ prolapse
Other names: mesh pelvic floor repari
Time frame: 12-months
Success is determined by achievement of an overall POP-Q score of ICS Stage ≤1, without further re-intervention for POP.
Time frame: 24 months
Success is determined by achievement of an overall POP-Q score of ICS Stage ≤1, without further re-intervention for POP
Time frame: 12 months
Success will be determined by achievement of treated compartment POP-Q score of ICS Stage ≤1, without further re-intervention for POP.
Time frame: 24 months
Success will be determined by achievement of treated compartment POP-Q score of ICS Stage ≤1, without further re-intervention for POP.
Time frame: 12 months
Success defined as the leading edge within the hymen (i.e. all POP-Q values to be less than 0, without further re-intervention for POP)
Time frame: 24 months
Success defined as the leading edge within the hymen (i.e. all POP-Q values to be less than 0, without further re-intervention for POP)
Time frame: 12 months
Time frame: 24 months
Time frame: 24 months
Time frame: 12 months
Time frame: 12 months
POPDI is a sub score of PFDI-20
Time frame: 24 months
POPDI is a sub score of PFDI-20
Time frame: 12 months
POPDI is a sub scores of PFDI-20
Time frame: 24 months
POPDI is a sub score of PFDI-20
Time frame: 12 months
CRADI is a sub score of PFDI-20
Time frame: 24 months
CRADI is a sub score of PFDI-20
Time frame: 12 months
CRADI is a sub score of PFDI-20
Time frame: 24 months
CRADI is a sub score of PFDI-20
Time frame: 12 months
UDI is a sub score of PFDI-20
Time frame: 24 months
UDI is a sub score of PFDI-20
Time frame: 12 months
UDI is a sub score of PFDI-20
Time frame: 24 months
UDI is a sub score of PFDI-20
Time frame: 12 months
Time frame: 24 months
Time frame: 12 months
Time frame: 24 months
Time frame: 12 months
Time frame: 24 months
Time frame: 12 months
POPIQ is a sub-score of PFIQ-7
Time frame: 24 months
POPIQ is a sub-score of PFIQ-7
Time frame: 12 months
POPIQ is a sub-score of PFIQ-7
Time frame: 24 months
POPIQ is a sub-score of PFIQ-7
Time frame: 12 months
CRAIQ is a sub-score of PFIQ-7
Time frame: 24 months
CRAIQ is a sub-score of PFIQ-7
Time frame: 12 months
CRAIQ is a sub-score of PFIQ-7
Time frame: 24 months
CRAIQ is a sub-score of PFIQ-7
Time frame: 12 months
UIQ is a sub-score of PFIQ-7
Time frame: 24 months
UIQ is a sub-score of PFIQ-7
Time frame: 12 months
UIQ is a sub-score of PFIQ-7
Time frame: 24 months
UIQ is a sub-score of PFIQ-7
Time frame: 12 months
In subjects sexually active at baseline, assessment of sexual function
Time frame: 24 months
In subjects sexually active at baseline, assessment of sexual function
Time frame: 12 months
In subjects sexually active at baseline, assessment of sexual function
Time frame: 24 months
In subjects sexually active at baseline, assessment of sexual function
Time frame: ongoing
Time frame: perioperative
From time to first incision to time of last suture used to secure VSD
Time frame: 24 hours post surgery and at the 3-4 week visit
Time frame: 24 hrs post-surgical
Time frame: 3-4 week visit
Measured by visual analogue scale
Time frame: 3-4 week visit
Measured by visual analogue scale
Time frame: 3-4 week visit
Measured by visual analogue scale
Time frame: 12 month visit
assessed on a 5 point Likert scale
Time frame: 24 month visit
assessed on a 5 point Likert scale
Ethicon, Inc.
Industry
A Prospective, Multi-centre Study to Evaluate the Clinical Performance of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Procedure for Pelvic Organ Prolapse
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02890498
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Nîmes, France
View Trial DetailsNCT06532292
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Taipei, Taiwan
View Trial DetailsNCT07554651
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dnipro, Ukraine
View Trial DetailsNCT07552337
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Diyarbakır, Turkey (Türkiye)
View Trial Details